- Principle Investigator, of Phase IV, Open-label, non-comparative, multicentric, trial, titled ‘Use of Meropenem in the treatment of Moderate and Severe Infections’ in 2003.
- Investigator (Unblinded Physician) in, global, multicenter, double-blind, comparative, randomized, Phase III trial, to evaluate `The efficacy and safety of Micafungin versus Liposomal Amphotericin B in the treatment of Invasive Candidiasis and Candidaemia`, between 2003 to 2004.
- Investigator (Unblinded Physician) in Phase III, global, randomized double-blind comparative study of`` Micafungin versus Caspofungin as an antifungal treatment in patients with Invasive Candidiasis and Candidaemia`, in 2005.
- Abovementioned trials subjected to US FDA audit
Trained in ICH-GCP (International Conference on Harmonisation Regulations - Good Clinical Practices).
Centre Principal Investigator, in the Writing Group of the Global Asthma Network Study Group- 2013
